Literature DB >> 12740829

Interaction of hepatitis B virus with cells.

Nir Paran1, Arik Cooper, Yosef Shaul.   

Abstract

Virus infection is initiated by recognition and attachment of the virus to the cell surface. Despite the fact that this interaction determines the virus-related pathogenesis, its molecular basis remained obscure for HBV. This process is mediated primarily by the viral envelope and the cellular receptors. HBV infection is not exceptional in this regard but its putative receptors have not been identified yet. The recent development of protocols to establish HBV susceptible cell lines and unique tools to measure HBV-cell attachment at a single cell resolution set the stage for the study of HBV-host cell interaction. These studies revealed that the QLDPAF epitope of the HBV surface antigen large protein (LHBsAg) plays a major role in this process. Quantitative measurements suggested the presence of a second player in this process and both act synergistically to improve cell attachment. As the step of virus-cell attachment is potentially susceptible to specific inhibitors, understanding the molecular basis of virus-cell attachment can be expected to have therapeutic impacts. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12740829     DOI: 10.1002/rmv.376

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  4 in total

Review 1.  Nanocaged platforms: modification, drug delivery and nanotoxicity. Opening synthetic cages to release the tiger.

Authors:  Mahdi Karimi; Parham Sahandi Zangabad; Fatemeh Mehdizadeh; Hedieh Malekzad; Alireza Ghasemi; Sajad Bahrami; Hossein Zare; Mohsen Moghoofei; Amin Hekmatmanesh; Michael R Hamblin
Journal:  Nanoscale       Date:  2017-01-26       Impact factor: 7.790

Review 2.  Hepatoepigenetic Alterations in Viral and Nonviral-Induced Hepatocellular Carcinoma.

Authors:  Mankgopo M Kgatle; Mashiko Setshedi; Henry N Hairwadzi
Journal:  Biomed Res Int       Date:  2016-12-26       Impact factor: 3.411

3.  Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles.

Authors:  Satadru Jha; Federico Ramadori; Santina Quarta; Alessandra Biasiolo; Enrica Fabris; Paola Baldan; Gaetano Guarino; Mariagrazia Ruvoletto; Gianmarco Villano; Cristian Turato; Angelo Gatta; Fabrizio Mancin; Patrizia Pontisso; Paolo Scrimin
Journal:  Bioconjug Chem       Date:  2016-11-02       Impact factor: 4.774

4.  Liver cell specific targeting by the preS1 domain of hepatitis B virus surface antigen displayed on protein nanocages.

Authors:  Masaharu Murata; Sayoko Narahara; Kaori Umezaki; Riki Toita; Shigekazu Tabata; Jing Shu Piao; Kana Abe; Jeong-Hun Kang; Kenoki Ohuchida; Lin Cui; Makoto Hashizume
Journal:  Int J Nanomedicine       Date:  2012-08-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.